Vermont Watchdogs Proposed Broader Healthcare Oversight

State regulators may expand cost oversight beyond hospitals as expenses in non-regulated sectors drive rising premiums.

Updated on Oct. 13, 2026 in Healthcare

Screen-print poster illustration of a wooden medicine cabinet in a rural Vermont landscape, evoking structural healthcare oversight policy.
Vermont regulators proposed expanding healthcare cost oversight to include pharmaceuticals, aiming to curb rising insurance premiums across the state. AI Illustration. Upload story photo >

Live Poll

Should government regulators expand healthcare oversight to include all private and out-of-state medical costs?

Following a 16-month engagement that concluded in September 2026, an independent watchdog group proposed that Vermont regulators expand oversight beyond hospital budgets. The group suggests linking insurance reimbursement rates directly to affordable premium caps to address rising costs.

Why it matters

Regulators cannot rely solely on hospital cost-cutting to manage systemic expenses, as 57% of healthcare claim costs currently fall outside the board's reach. This shift seeks to address pharmaceutical prices that currently sit 13% higher than the New England average.

Regulated hospitals account for 43% of total claim costs, while the remaining 57% exist outside current board oversight. UVM Medical Center remains under a mandate to achieve $300 million in expense reductions over three years.

The players

UVM Medical Center

A major academic medical center operating under a $300 million expense reduction mandate.

Green Mountain Care Board

A state regulatory body that oversees budgets for 14 hospitals across Vermont.

Owen Foster

The departing chair of the Green Mountain Care Board who oversaw regional hospital regulation.

The details

The oversight group suggests that the Green Mountain Care Board shift its approach by first setting total affordable premiums. Regulators would then use that figure to mandate insurance reimbursement rates, theoretically forcing cost discipline across the entire system rather than just within hospital walls. This strategy aims to curb spending in categories like pharmaceuticals that exceed regional benchmarks.

Timeline

  1. Spring 2025: Watchdog group began assessing UVM Health finances.

  2. May 2025: Liaison team began analyzing hospital finances and operations.

  3. September 2026: Liaison group concluded their 16-month oversight engagement.

  4. 2027: UVM Health implemented an aggressive expense-cutting budget.

Market Landscape

The proposal marks a shift from the targeted 2025 settlement between UVM Medical Center and the Green Mountain Care Board. It signals a move toward state-wide systemic pricing rather than hospital-specific budget management.

Operators should prepare for the possibility of state-mandated reimbursement changes that may compress margins across non-hospital services. Monitoring the Green Mountain Care Board for new rules on premium-linked pricing is essential for long-term budget planning.

The takeaway

Total system cost control is replacing facility-specific oversight as the primary regulatory objective in Vermont. Operators should track the board's upcoming transition in leadership as a signal for how quickly these broader reimbursement policies may take hold.

What happens next

Stephen Gorman will conduct progress reviews of UVM Health operations every three months throughout 2027.

Further reading

Learn more about the evolving regulatory environment in the Healthcare section.

Source note: This article includes information reported by VTDigger.

Live Poll

Should government regulators expand healthcare oversight to include all private and out-of-state medical costs?